- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bayer AG PK ADR (BAYRY)
Track today's live Bayer AG PK ADR (BAYRY) share price, performance and key data on this page with our current OTC Markets:BAYRY stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Bayer AG PK ADR share price on the OTC Markets exchange. Use the dropdown to switch exchange for the BAYRY share price, head to our technical summary section, which provides analysis on Bayer AG PK ADR share price buy/sell indicators using real-time data (or discuss the Bayer AG PK ADR (BAYRY) stock price today with other investors in the Bayer AG PK ADR OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC:BAYRY share price (ISIN: US0727303028) to enhance your trading decisions with our free investment tools and resources.
What Is the Bayer AG PK ADR Share Price Today?
The Bayer AG PK ADR share price today is 15.33.
What Is the Stock Symbol for Bayer AG PK ADR
The stock symbol (or 'ticker') for Bayer AG PK ADR is "BAYRY."
What Stock Exchange Does Bayer AG PK ADR Trade On?
Bayer AG PK ADR is listed and trades on the OTC Markets stock exchange.
Is Bayer AG PK ADR a Good Stock to Buy?
Determining whether Bayer AG PK ADR (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current OTC:BAYRY share price (ISIN: US0727303028) to enhance your trading decisions with our free investment tools and resources.
What Is the Bayer AG PK ADR Share Price Today?
The Bayer AG PK ADR share price today is 15.33.
What Is the Stock Symbol for Bayer AG PK ADR
The stock symbol (or 'ticker') for Bayer AG PK ADR is "BAYRY."
What Stock Exchange Does Bayer AG PK ADR Trade On?
Bayer AG PK ADR is listed and trades on the OTC Markets stock exchange.
Is Bayer AG PK ADR a Good Stock to Buy?
Determining whether Bayer AG PK ADR (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
OTC Markets
Symbol | Exchange | Currency | |||
|---|---|---|---|---|---|
| BAYRY | · | OTC Markets | · | USD | |
| 0P6S | · | London | · | EUR | |
| BAYGn | · | Derived | · | EUR | |
| BAYGn | · | Xetra | · | EUR | |
| BAYGn | · | Switzerland | · | CHF | |
| BAYG | · | Milan | · | EUR | |
| BAYGn | · | Vienna | · | EUR | |
| BAYG | · | Budapest | · | HUF | |
| BAY1 | · | Warsaw | · | PLN | |
| BAYN | · | Bucharest | · | RON | |
| BAYNN | · | Mexico | · | MXN | |
| BAYGn | · | Frankfurt | · | EUR | |
| BAYGn | · | TradeGate | · | EUR | |
| BAYNd | · | BATS Europe | · | EUR | |
| BAYGn | · | Dusseldorf | · | EUR | |
| BAYGn | · | Hamburg | · | EUR | |
| BAYNN | · | BIVA | · | MXN |
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.06
15.55
52 wk Range
7.56
15.84
BAYRY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.0615.55
52 wk Range
7.5615.84
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BAYRY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
16.07
Upside
+4.83%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy
Analyst Ratings
2 Buy
2 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 16.07
(+4.83% Upside)
Bayer AG PK ADR Earnings Call Summary for Q3/2026
- Bayer Q3 EPS of $0.0868 missed estimates by 28%, yet shares surged 7% on raised full-year EBITDA and cash flow guidance plus lower debt targets.
- Pharma division drove growth with Nubeqa showing 58% risk reduction data; asundexian gained first global approval in China, U.S. launch set for Q1 2027.
- Company raised 2026 EBITDA guidance to €9.8-10.3B, improved FCF outlook to negative €0.5-1.5B, and lowered net debt target to €28-29B.
- Crop Science faces ongoing headwinds from weather, generics, and regulation, though seeds/traits performed well; litigation cash outflows remain elevated.
- Management prioritizes debt reduction before dividend increases; expects Pharma margin of 25-27% for 2026, up from prior 23-25% guidance range.
Last Updated: 03/11/2026, 15:00
Read Full TranscriptEarnings
Latest Release
03/11/2026
EPS / Forecast
0.09 / 0.12
Revenue / Forecast
11.25B / 11.32B
Compare BAYRY to Peers and Sector
Metrics to compare | BAYRY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBAYRYPeersSector | |
|---|---|---|---|---|
P/E Ratio | −36.6x | −7.8x | −0.2x | |
PEG Ratio | 0.06 | 0.03 | 0.00 | |
Price/Book | 1.8x | 1.4x | 2.6x | |
Price / LTM Sales | 1.2x | 1.0x | 2.8x | |
Upside (Analyst Target) | 2.4% | 16.3% | 65.6% | |
Fair Value Upside | Unlock | 9.9% | 10.0% | Unlock |
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. It has a commercial agreement with Neste to Jointly scale newgold winter canola for biofuels production. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Bayer AG PK ADR (OTC Markets: BAYRY) Share Price Today?
The Bayer AG PK ADR stock price today is 15.33 USD.
What Stock Exchange Does Bayer AG PK ADR (BAYRY) Trade On?
Bayer AG PK ADR is listed and trades on the OTC Markets.
What Is the Ticker (Stock Symbol) for Bayer AG PK ADR?
The stock symbol (also called a 'ticker') for Bayer AG PK ADR is "BAYRY."
Does Bayer AG PK ADR Pay Dividends? What’s The Current BAYRY Dividend Yield?
Yes, BAYRY Pays Dividends to its Shareholders. The current Bayer AG PK ADR dividend yield is 0.2%%.
What Is the Current Bayer AG PK ADR Market Capitalisation?
As of today, Bayer AG PK ADR (OTC Markets: BAYRY) market cap is 60.72B USD.
What Is Bayer AG PK ADR's (BAYRY) Earnings Per Share (TTM)?
The Bayer AG PK ADR EPS is currently -1.67 (Trailing Twelve Months).
When Is the Next Bayer AG PK ADR Earnings Date?
Bayer AG PK ADR's next earnings report will be released on 24/02/2027.
Is BAYRY a Buy or Sell From a Technical Analyst Perspective?
Based on today's Bayer AG PK ADR moving averages and other technical indicators, the daily buy/sell signal for BAYRY stock is Strong Buy.
How Many Times Has Bayer AG PK ADR Stock Split?
Bayer AG PK ADR has split 3 times. (See the BAYRY stock split history page for full effective split date and price information.)
How Many Employees Does Bayer AG PK ADR Have?
Bayer AG PK ADR has 87280 employees, based on their latest Companies House report.
What is the current trading status of Bayer AG PK ADR (OTC Markets: BAYRY)?
As of 07/11/2026, Bayer AG PK ADR (BAYRY) is trading at a share price of 15.33 USD, with a previous close of 15.33 USD. The stock has fluctuated within a day range of 15.06 USD to 15.55 USD, while its 52-week range spans from 7.56 USD to 15.84 USD.
What Is Bayer AG PK ADR (BAYRY) Price Target According to Analysts?
The average 12-month price target for Bayer AG PK ADR is 16.07 USD, with a high estimate of 16.8 USD and a low estimate of 15.3 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +4.83% Upside potential.
What Is the BAYRY Premarket Price?
BAYRY's last pre-market stock price is 15.14 USD. The pre-market share volume is 23,370.00, and the stock has decreased by -0.38, or -2.45%.
What Is the BAYRY After Hours Price?
BAYRY's last after hours stock price is 15.36 USD, the stock has decreased by 0.03, or 0.20%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.